HomeCompareRGDFF vs MRK

RGDFF vs MRK: Dividend Comparison 2026

RGDFF yields 367.51% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RGDFF wins by $6195.47M in total portfolio value
10 years
RGDFF
RGDFF
● Live price
367.51%
Share price
$0.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6195.53M
Annual income
$4,035,484,184.30
Full RGDFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RGDFF vs MRK

📍 RGDFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRGDFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RGDFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RGDFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGDFF
Annual income on $10K today (after 15% tax)
$31,238.52/yr
After 10yr DRIP, annual income (after tax)
$3,430,161,556.66/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RGDFF beats the other by $3,430,153,228.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGDFF + MRK for your $10,000?

RGDFF: 50%MRK: 50%
100% MRK50/50100% RGDFF
Portfolio after 10yr
$3097.79M
Annual income
$2,017,746,991.22/yr
Blended yield
65.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RGDFF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
82.0
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGDFF buys
0
MRK buys
0
No recent congressional trades found for RGDFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRGDFFMRK
Forward yield367.51%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$6195.53M$56.8K
Annual income after 10y$4,035,484,184.30$9,798.13
Total dividends collected$5991.98M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: RGDFF vs MRK ($10,000, DRIP)

YearRGDFF PortfolioRGDFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$47,451$36,751.19$11,206$366.19+$36.2KRGDFF
2$213,753$162,980.19$12,650$502.35+$201.1KRGDFF
3$914,861$686,145.25$14,407$694.19+$900.5KRGDFF
4$3,723,477$2,744,575.66$16,585$967.82+$3.71MRGDFF
5$14,423,748$10,439,627.60$19,342$1,363.89+$14.40MRGDFF
6$53,228,092$37,794,681.62$22,913$1,947.19+$53.21MRGDFF
7$187,303,654$130,349,595.99$27,662$2,823.89+$187.28MRGDFF
8$629,092,978$428,678,068.07$34,159$4,173.35+$629.06MRGDFF
9$2,018,729,784$1,345,600,297.20$43,337$6,308.80+$2018.69MRGDFF
10$6,195,525,053$4,035,484,184.30$56,776$9,798.13+$6195.47MRGDFF

RGDFF vs MRK: Complete Analysis 2026

RGDFFStock

Reunion Gold Corporation engages in the acquisition, exploration, and development of gold mineral properties in South America. Its principal projects include Oko West Project covering an area of 10,880 acres in Guyana; NW Extension project comprising three rights of exploration that covers an area of 925 square kilometers in Suriname; Boulanger that covers an area of 38.42 km2 in French Guiana; and Dorlin, consisting of an 84 km2 exploitation permit in French Guiana. The company was formerly known as New Sleeper Gold Corporation and changed its name to Reunion Gold Corporation in June 2006. Reunion Gold Corporation is based in Longueuil, Canada.

Full RGDFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RGDFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGDFF vs SCHDRGDFF vs JEPIRGDFF vs ORGDFF vs KORGDFF vs MAINRGDFF vs JNJRGDFF vs ABBVRGDFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.